PADI4 gene in multiple sclerosis: a family-based association study

Area of Science:

• Neuroimmunology
• Genetics
• Biochemistry

Background:

• Multiple sclerosis (MS) involves myelin basic protein (MBP) citrullination by peptidylarginine deiminase (PAD).
• This modification might play a key role in MS pathogenesis.
• The PADI4 enzyme isoform is found in inflammatory cells within MS lesions.

Purpose of the Study:

• To examine the association between the PADI4 gene and susceptibility to multiple sclerosis.
• To investigate the potential role of PADI4 in MS pathogenesis through genetic analysis.

Main Methods:

• A family-based association study design was employed.
• Three single nucleotide polymorphisms (SNPs) in the PADI4 gene were genotyped using restriction fragment length polymorphism (RFLP).
• Analysis included single SNP and haplotype associations, as well as stratification by DRB1*15 status and disease severity.

Main Results:

• No significant association was found between individual PADI4 SNPs or their haplotypes and MS susceptibility.
• Stratified analyses based on DRB1*15 positivity or disease severity also revealed no significant genetic associations.
• These findings suggest PADI4 may not be a major genetic factor for MS.

Conclusions:

• The PADI4 gene does not appear to play a major role in conferring susceptibility to multiple sclerosis.
• Further research is needed to fully elucidate the genetic factors regulating deimination in MS.
• The role of PAD enzymes in MS pathogenesis warrants continued investigation.